Longeveron Inc.

LGVN
$0.73 (- $0.07 - 8.75%)
Last updated: 2026-06-06 06:59 UTC
LGVN Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS54303L1044
CUSIP54303L104
Market Price0.73
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.98
Market Cap$11.4M
Book Value0.47
Price to Book1.126
Beta0.17
52w High2.24
52w Low0.52
Next Earnings DateN/A

Longeveron Inc. trades under ticker LGVN on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US54303L1044, CUSIP 54303L104. Also searched as Longeveron.

Related researchLGVN stock priceLGVN share priceLongeveron stockLongeveron share price54303L104
About the Company
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Price History